Gastrointestinal Neoplasms
Information
- Disease name
- Gastrointestinal Neoplasms
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT04592913 | Active, not recruiting | Phase 3 | Assessing Durvalumab and FLOT Chemotherapy in Resectable Gastric and Gastroesophageal Junction Cancer | November 17, 2020 | September 27, 2027 |
NCT02795988 | Active, not recruiting | Phase 1/Phase 2 | A Study of IMU-131(HER-Vaxx) and Chemotherapy Compared to Chemotherapy Only in Patients With HER2 Positive Advanced Gastric Cancer | August 30, 2017 | August 2024 |
NCT06260150 | Active, not recruiting | N/A | Application of IPC During Surgery to Prevent Venous Thrombosis in Gastrointestinal Surgery Patients. | April 1, 2023 | April 2024 |
NCT04919824 | Active, not recruiting | N/A | Monopolar Current Cutting Knife vs Bipolar RFA Knife | January 25, 2022 | December 30, 2024 |
NCT01946854 | Active, not recruiting | N/A | Crossover Trial of Systemic Chemotherapy in Patients With Metastatic Well-Differentiated Mucinous Appendiceal Adenocarcinomas With Pseudomyxoma Peritonei | July 16, 2013 | July 31, 2025 |
NCT05551052 | Active, not recruiting | CRC Detection Reliable Assessment With Blood | September 8, 2022 | July 2024 | |
NCT00289445 | Completed | Phase 1/Phase 2 | Study With Mitomycin c/5-FU/FA in Pretreated Gastrointestinal Cancer Patients With Metastases (>= Second-line Treatment) | September 1999 | March 2006 |
NCT00390182 | Completed | Phase 1/Phase 2 | Low Dose Upper Abdominal Radiation Therapy (LD-UART) + Gemcitabine in Patients With Advanced, Unresectable Pancreatic Cancer (PC) | October 2003 | May 2011 |
NCT00422409 | Completed | N/A | Endoscopic Stenting of Gastrointestinal Cancer | October 2006 | April 2010 |
NCT00436657 | Completed | Phase 1 | Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer | February 2007 | April 2011 |
NCT00570635 | Completed | Phase 2 | A Phase 2 Study of XL820 in Adults With Advanced GIST Resistant to Imatinib and/or Sunitinib | December 2007 | May 2009 |
NCT00990535 | Completed | Phase 2 | High Dose Somatostatin Analogues in Neuroendocrine Tumors | January 2006 | December 2008 |
NCT01291407 | Completed | Phase 1 | A Phase I Study of S-1 in Combination With Radiotherapy in Locally Advanced or Recurrent Gastric Cancer | November 2010 | September 2013 |
NCT01415609 | Completed | Endoscopic Submucosal Dissection Registry | August 2010 | March 2012 | |
NCT01567488 | Completed | Phase 2 | Phase II Study of Everolimus Combined With Octreotide LAR to Treat Advanced GI NET | June 8, 2011 | June 7, 2017 |
NCT04694521 | Completed | N/A | Outcomes of Side-to-end Versus End-to-end Colorectal Anastomosis in Non-emergent Sigmoid and Rectal Cancers: Randomized Controlled Clinical Trial | September 2016 | September 2020 |
NCT00041808 | Completed | Phase 1/Phase 2 | Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver | July 2001 | April 2003 |
NCT00120939 | Completed | Phase 1 | Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer | ||
NCT00190801 | Completed | Phase 2 | Phase 2 Study on Use of a Combination of Pemetrexed in Patients With Advanced Gastric Carcinoma | September 2003 | September 2005 |
NCT00196885 | Completed | Phase 2 | Effect of an Antioxidant on Cancer-Cachectic Patients Undergoing Exercise Training | December 2003 | December 2006 |
NCT00247338 | Completed | Phase 4 | The Impact of Low Calorie and Low Nitrogen Parenteral Nutrition Support on the Clinical Outcome of Postoperative Patients | April 2005 | May 2006 |
NCT01693445 | Completed | Phase 1 | S-1, Oxaliplatin, and Irinotecan for Advanced Gastrointestinal Cancer | June 2012 | August 2014 |
NCT01816607 | Completed | Functional MRI of Hypoxia-mediated Rectal Cancer Aggressiveness | October 2013 | December 2017 | |
NCT01982994 | Completed | N/A | Intervention to Motivate Standing &Walking in Gastrointestinal Cancer Surgical Patients | October 2013 | December 2018 |
NCT01996306 | Completed | Phase 3 | A Phase III Study of 2nd-line XELIRI ± Bevacizumab vs. FOLFIRI ± Bevacizumab in mCRC | December 2, 2013 | June 30, 2018 |
NCT02444572 | Completed | Phase 4 | Comparison of Thromboembolic Events in Patients Undergoing Thromboprophylactic Treatment With ENOXA® vs Lovenox® | October 2015 | July 10, 2020 |
NCT02454647 | Completed | Induction Chemotherapy, Chemoradiotherapy and Surgery in Locally Advanced Gastric Cancer Patients | September 2013 | March 2015 | |
NCT02485561 | Completed | N/A | Evaluating Strategies to Present Colon Cancer Screening Information | June 1, 2015 | January 31, 2017 |
NCT02486094 | Completed | Study of PRoliferation and Apoptosis in Rectal Cancer, Predictive & Prognostic biOmarkers: Histopathology and Imaging | June 2015 | June 7, 2017 | |
NCT02507414 | Completed | N/A | Mesenteric Traction Syndrome During Upper Gastrointestinal Surgery | August 2014 | September 2016 |
NCT02951273 | Completed | Cerebral Blood Flow During Propofol Anaesthesia | December 8, 2016 | July 6, 2017 | |
NCT03037385 | Completed | Phase 1/Phase 2 | Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors | March 17, 2017 | March 21, 2024 |
NCT03309917 | Completed | N/A | The Effect of Blood Pressure on Cerebral Blood Flow During Propofol Anesthesia | December 27, 2017 | April 19, 2018 |
NCT03549494 | Completed | Phase 2 | Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction | October 25, 2018 | February 15, 2023 |
NCT03559543 | Completed | Phase 2 | Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma | October 25, 2018 | January 15, 2024 |
NCT03674294 | Completed | Phase 3 | Aprepitant Triple Therapy for the Prevention of CINV in Nondrinking and Young Women Who Received Moderately Emetogenic Chemotherapy | August 4, 2015 | June 1, 2020 |
NCT04010227 | Completed | N/A | Telephone Support for Advanced Gastrointestinal Cancer Patients and Caregivers | September 16, 2019 | June 8, 2021 |
NCT04080843 | Completed | Phase 2 | Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC Patients | November 15, 2019 | July 1, 2022 |
NCT04137289 | Completed | Phase 1 | A Study to Find a Safe and Effective Dose of BI 905711 in Patients With Advanced Gastrointestinal Cancer | March 11, 2020 | November 27, 2023 |
NCT04145297 | Completed | Phase 1 | Ulixertinib (BVD-523) and Hydroxychloroquine in Patients w Advanced MAPK-Mutated Gastrointestinal Adenocarcinomas | March 17, 2020 | August 18, 2022 |
NCT04361227 | Completed | Utility of OverStitch Sx After ESD | July 2, 2020 | October 20, 2022 | |
NCT04670718 | Completed | N/A | The Use of a OCT Probe in Assessment of Endoscopic and Surgical Resection Specimen of Gastrointestinal Tract | December 10, 2020 | June 30, 2021 |
NCT04673136 | Completed | N/A | Usefulness of GI-GENIUS in FIT-based Colorectal Cancer Screening Program. | April 1, 2021 | March 31, 2022 |
NCT00001431 | Completed | Phase 1 | A Phase I Trial of Gemcitabine and Radiation in Locally Advanced Unresectable Cancer of the Pancreas | February 1995 | November 2000 |
NCT04752670 | Completed | ConMed Beamer Study | May 27, 2021 | May 1, 2022 | |
NCT05012527 | Completed | Retrospective Review of Gastrointestinal System Endoscopy Procedures | June 11, 2021 | October 1, 2021 | |
NCT05113134 | Completed | N/A | Transvaginal Versus Transabdominal Extraction of Laparoscopically-excised Specimen | March 2, 2015 | July 24, 2020 |
NCT05163665 | Completed | N/A | Cost-effective Analysis of Two Approximation Devices in Closure of Gastrointestinal Defects | August 23, 2022 | September 11, 2023 |
NCT05178095 | Completed | N/A | Artificial Intelligence in Colonic Polyp Detection | September 30, 2020 | June 1, 2023 |
NCT05190042 | Completed | N/A | Clinical Study on Continuous Suture of Endoscopic Mucosal Defects | January 18, 2022 | July 30, 2022 |
NCT06048146 | Enrolling by invitation | N/A | A Prospective, Multicenter Randomized Controlled Study of the Application of Preoperative FOLFOXIRI Chemotherapy Combined With Lateral Lymph Node Dissection in Low- and Medium-lying Rectal Cancer With Lateral Lymph Node Metastasis | October 1, 2022 | September 1, 2029 |
NCT05552729 | Not yet recruiting | Phase 1/Phase 2 | Effects of Different Doses of Vitamin D on Cancer-related Cognitive Impairment in Patients With Gastrointestinal Tumors | September 22, 2022 | December 30, 2022 |
NCT05280210 | Not yet recruiting | N/A | PTC in Personalizing Neoadjuvant Therapy for Patients With Advanced Gastrointestinal Tumor | April 1, 2022 | December 31, 2024 |
NCT04949282 | Recruiting | Spanish Series of Patients Treated With the Radionuclide Lutetium177 | May 10, 2021 | December 31, 2035 | |
NCT04937647 | Recruiting | Evaluation of Neoplasia With Artificial Intelligence in Gastrointestinal Endoscopy | June 16, 2021 | June 15, 2023 | |
NCT04907643 | Recruiting | N/A | Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes | October 5, 2021 | March 2026 |
NCT05106244 | Recruiting | N/A | Remote Real-Time Guidance System in Home Care of Patients With PICC or PORT | January 1, 2022 | August 30, 2024 |
NCT02196935 | Recruiting | Los Angeles Prospective GI Biliary and EUS Series | September 2010 | December 2025 | |
NCT04755920 | Recruiting | Phase 2 | SGM-101 in Colorectal Brain Metastases. | January 1, 2024 | February 2026 |
NCT05772546 | Recruiting | Phase 2 | Avatrombopag vs. Placebo for CIT in GI Malignancies | November 1, 2023 | July 31, 2025 |
NCT01750619 | Recruiting | Clinical Outcomes of the Endoscopic Resection of Premalignant and Malignant Gastrointestinal Lesions | July 2011 | December 2024 | |
NCT05159479 | Recruiting | Defining Robust Predictors of Chemotherapy Related Cardiotoxicity | October 13, 2021 | July 1, 2024 | |
NCT05494060 | Recruiting | Phase 2 | XELOX Combined With Anlotinib and Penpulimab vs XELOX as Adjuvant Therapy in ctDNA Positive Gastric and Esophagogastric Junction Adenocarcinoma | March 16, 2022 | February 2027 |
NCT04426669 | Recruiting | Phase 1/Phase 2 | A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering | May 15, 2020 | January 2024 |
NCT05980416 | Recruiting | Phase 1 | Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2 | August 10, 2023 | December 2028 |
NCT03597581 | Recruiting | Phase 1 | A Study of RGX-202-01 (Ompenaclid) as Combination Therapy in RAS Mutant Advanced Colorectal Cancer | June 5, 2018 | December 31, 2024 |
NCT03602677 | Recruiting | N/A | Indocyanine Green Fluorescence Imaging in Prevention of Colorectal Anastomotic Leakage | September 24, 2018 | December 1, 2023 |
NCT06301828 | Recruiting | Phase 2 | Endostar Combined With SBRT and Envafolimab in the Treatment of Advanced Gastrointestinal Tumors | February 21, 2024 | February 21, 2026 |
NCT04393584 | Recruiting | Phase 2/Phase 3 | FOLFIRINOX vs FLOT Chemotherapy for Resectable Gastric or Esophagogastric Junction Adenocarcinoma | January 29, 2019 | January 1, 2026 |
NCT04363983 | Recruiting | N/A | Interaction Between Host, Microenvironment and Immunity on Gastrointestinal Neoplasms | January 13, 2021 | January 2031 |
NCT06365866 | Recruiting | N/A | Evaluate the Efficacy of Adding Intraluminal Brachytherapy After CCRT for Local-regional Thoracic Esophageal Cancer. | February 19, 2024 | December 2024 |
NCT04084249 | Recruiting | N/A | ctDNA-guided Surveillance for Stage III CRC, a Randomized Intervention Trial | January 1, 2020 | June 30, 2028 |
NCT05252078 | Recruiting | Phase 2 | Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma Patients | June 2, 2022 | November 2026 |
NCT05160168 | Terminated | Phase 1/Phase 2 | A Study of THE-630 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST) | January 3, 2022 | February 2, 2024 |
NCT02820077 | Terminated | N/A | Hemostatic Powder Versus Clinical Management for the Treatment of Upper Gastrointestinal Bleeding From Tumor Lesions | August 6, 2016 | August 27, 2020 |
NCT02859064 | Terminated | Phase 2 | Study of Lanreotide in Patients With Metastatic Gastrointestinal Neuroendocrine Tumors Who Are Undergoing Liver-directed Radioembolization With Yttrium-90 Microspheres | July 28, 2017 | June 10, 2022 |
NCT00300027 | Terminated | Phase 1 | Study of BMS-582664 in Combination With Either FOLFIRI or FOLFOX for Gastrointestinal (GI) Malignancies | April 2006 | |
NCT04644315 | Terminated | Phase 2 | A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors | May 24, 2021 | May 16, 2022 |
NCT01624090 | Terminated | Phase 2 | Mithramycin for Lung, Esophagus, and Other Chest Cancers | September 6, 2012 | September 27, 2019 |
NCT01790035 | Terminated | Phase 1 | Probiotic LGG for Prevention of Side Effects in Patients Undergoing Chemoradiation for Gastrointestinal Cancer | August 19, 2014 | December 12, 2021 |
NCT01853241 | Terminated | Prospective Randomized Trial of Anterograde Single Balloon Versus Spirus Enteroscopy | May 2010 | January 2011 | |
NCT02080702 | Terminated | An International, Multicentric, Prospective, Observational Study to Evaluate Monosyn® Suture Material for Anastomoses in the Gastrointestinal Tract | August 2014 | June 2016 | |
NCT02417753 | Terminated | Phase 2 | AZD9150, a STAT3 Antisense Oligonucleotide, in People With Malignant Ascites | April 3, 2015 | April 7, 2016 |
NCT00767234 | Terminated | Permission to Collect Blood Over Time for Research | August 2008 | October 2011 | |
NCT02744651 | Terminated | N/A | EUS-Endodrill vs. EUS-FNA for Diagnosis of Submucosal Tumors in the Upper GI Tract | February 17, 2017 | December 31, 2021 |
NCT00452205 | Unknown status | Bone Marrow-derived Cells' Contribution to Tumor Formation and Inflammation | April 2007 | March 2017 | |
NCT03330964 | Unknown status | N/A | Clinical Trial of Electroacupuncture Stimulation on Prevention and Treatment of Oxaliplatin Neurotoxicity | September 1, 2017 | May 2018 |
NCT03303495 | Unknown status | Phase 3 | A Study of 2nd-line FOLFIRI ± Bevacizumab vs. Irinotecan ± Bevacizumab in mCRC | November 14, 2011 | December 31, 2018 |
NCT02837679 | Unknown status | N/A | Oncogeriatric Intervention and Follow-up at Home | January 2016 | January 2023 |
NCT03271255 | Unknown status | Phase 2 | Apatinib Versus Bevacizumab in Second-line Therapy for Colorectal Cancer(ABST-C) | May 23, 2018 | December 31, 2022 |
NCT02512328 | Unknown status | Phase 1 | Improvement of Colonoscopy Preparation by New Media (APP) | March 2015 | October 2015 |
NCT02866045 | Unknown status | Phase 3 | EUS-FNB vs. Single-incision Needle-knife (SINK) Biopsy for Gastrointestinal SELs | May 2016 | December 2018 |
NCT03488446 | Unknown status | Radiomics for Prediction of Lymph Node Metastasis in Gastric Cancer(RPLNM)(GIPMCS-1701) | August 30, 2017 | March 31, 2019 | |
NCT02860429 | Unknown status | Phase 4 | Clinical Trial of Cinobufacini Injection Combined With Oxaliplatin Regimen on Gastrointestine Carcinoma | September 2016 | |
NCT03065257 | Unknown status | Endoscopic Resection Multicenter Registry | March 15, 2017 | April 2020 | |
NCT01995942 | Unknown status | Molecular, Pathologic and MRI Investigation of the Prognostic and Redictive Importance of Extramural Venous Invasion in Rectal Cancer (MARVEL) Trial | June 7, 2013 | February 2, 2022 | |
NCT02005965 | Unknown status | Low Rectal Cancer Study (MERCURY II) | August 13, 2007 | March 11, 2021 | |
NCT02513849 | Unknown status | Phase 1 | Tamoxifen in Patients With Oesophageal Cancer | December 2015 | November 2018 |
NCT02169388 | Unknown status | Phase 1 | Intestinal Microflora in Colorectal Cancer (CRC) After Chemotherapy | June 2014 | January 2015 |
NCT03050333 | Unknown status | Efficacy and Safety of Endoscopic Resection | April 25, 2013 | December 31, 2023 | |
NCT02215837 | Unknown status | Phase 2 | Study of Autologous Tumor Lysate-pulsed D-CIK Combined With Chemotherapy for Gastric Cancer | August 2014 | May 2018 |
NCT02226224 | Unknown status | Endoscopic Ultrasound in Detailed T-staging of Upper GI Malignancies in Vitro | June 2014 | October 2020 | |
NCT02233205 | Unknown status | Phase 1/Phase 2 | Safety Study of Combining Ultrasound Microbubbles and Chemotherapy to Treat Malignant Neoplasms of Digestive System | October 2014 | June 2016 |
NCT02672774 | Unknown status | N/A | Novel Endoscopic Imaging Methods for the Evaluation of Blood Vessels in Gastrointestinal Cancers | October 2015 | September 2017 |
NCT02871245 | Unknown status | N/A | Clinical Trial on Acupuncture Therapy in Patients With Gastrointestinal Neoplasms Laparoscopic Surgery | September 21, 2016 | July 2017 |
NCT02450656 | Unknown status | Phase 1/Phase 2 | Afatinib and Selumetinib in Advanced KRAS Mutant and PIK3CA Wildtype Non-small Cell Lung Cancer | June 2015 | December 2019 |
NCT02785523 | Unknown status | Phase 3 | Clinical Trial on Ganoderma Spore Lipids Combined With Chemo in Patients With G.I. Cancers | May 2016 | |
NCT05322486 | Unknown status | Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases | October 29, 2020 | December 2022 | |
NCT05232357 | Unknown status | Early Phase 1 | Endoscopic Vital Nerve Staining in Gastrointestinal Diseases | March 1, 2022 | May 15, 2022 |
NCT03889626 | Unknown status | Phase 3 | The Maintenance Treatment of Apatinib/Capecitabine Versus Observation in Advanced Gastric Cancer | March 22, 2019 | March 22, 2024 |
NCT01037049 | Unknown status | Phase 2 | Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks | October 16, 2009 | December 8, 2019 |
NCT01422928 | Withdrawn | Phase 3 | Acupuncture for the Immune System in Radiation Cancer Patients | December 2010 | December 2013 |
NCT04811833 | Withdrawn | Gastrointestinal Anastomosis Using MonoPlus® Suture | July 2022 | December 2023 | |
NCT01031056 | Withdrawn | Collection of Biospecimen & Clinical Information in Patients w/ Gastrointestinal Cancers | January 2010 | January 2099 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D005770